01Jul
Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)
At the outset, Novartis is “lucky” – the settlement is relatively positive, despite its 2016 SEC enforcement action in China. Given Novartis weak culture of compliance (if anything, a better description may be a culture of non-compliance) and its status as a recidivist, Novartis could have been slammed with a stiffer enforcement action, including assignment of an independent corporate compliance monitor and a higher penalty. ...
By:
Michael Volkov
Related
On January 1, 2020, the new federal overtime rule takes effect. Other than in states with already-h...
Read More >
As previously discussed, the federal Department of Labor has begun the process of increasing the min...
Read More >
In today’s business climate, work always seems to be on the mind. But should it be? According to th...
Read More >
As we have all witnessed, the COVID-19 situation remains incredibly fluid and presents unique challe...
Read More >
Sugar Land Plastics Manufacturer Fired Employee for Complaining About Abuse, Federal Agency Charges ...
Read More >
It is well established that, in general, employers, whose employees are represented by a union, comm...
Read More >